ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Naringin ameliorates liver fibrosis in zebrafish by modulating IDO1-mediated lipid metabolism and inflammatory infiltration

Qin, Meng-chen; Li, Jun-jie; Zheng, Yan-tao; Li, Yun-jia; Zhang, Yu-xue; Ou, Rou-xuan; He, Wei-yi; Zhao, Jia-min; Liu, Su-tong; Liu, Ming-hao*; Lin, Hai-yan*; Gao, Lei*南方医科大学; 中国科学院研究生院; 1
Food & Function2023-11-27DOI: 10.1039/d3fo03858k
6阅读
引用收藏
分享

摘要

Liver fibrosis (LF) is an important reparative process in response to acute or chronic hepatic injury, which has the potential to advance towards cirrhosis and hepatocellular carcinoma. Dietary naringin consumption contributes to protection against LF in animal studies, while the exact protective mechanism of naringin remains unclear. This study aimed to investigate the molecular mechanisms behind the potential protective effect of naringin against TAA-induced LF in zebrafish. In this study, we utilized zebrafish to create the LF model and investigate the therapeutic mechanism of naringin. Firstly, we evaluated the changes in hepatic fibrosis and lipid accumulation in the liver following naringin treatment with oil red O, Nile red, and Sirius red and immunohistochemistry. In addition, we employed an ROS probe to directly measure oxidative stress and monitor inflammatory cell migration in a zebrafish transgenic line. Morpholino was used in the knockdown of IDO1 in order to verify its vital role in LF. Our findings demonstrated that naringin exhibited anti-inflammatory and anti-fibrotic action in conjunction with a reversal in lipid accumulation, oxidative stress and suppression of macrophage infiltration and activation of hepatic stellate cells. Furthermore, the results showed that the antifibrotic effect of naringin was removed upon IDO1 knockdown, proving that naringin exerts a protective effect by regulating IDO1. Naringin demonstrates remarkable protective effects against LF, effectively counteracting inflammation and hepatic steatosis in zebrafish liver. These findings suggest that naringin may function as an effective IDO1 inhibitor, holding the potential for clinical translation as a therapeutic agent for the treatment of LF. @@@ Liver fibrosis (LF) is an important reparative process in response to acute or chronic hepatic injury, which has the potential to advance towards cirrhosis and hepatocellular carcinoma.

学科与关键词

关键词
KYNURENINE PATHWAY ENZYMESHEPATIC STELLATE CELLSMECHANISMSMACROPHAGESACTIVATIONTARGET
相关
加载中…
  • Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
    Li, Yunjia; Yang, Menghan; Lin, Haiyan; Yan, Weixin; Deng, Guanghui; Ye, Haixin; Shi, Hao; Wu, Chaofeng; Ma, Guoliang; Xu, Shu; Tan, Qinxiang*; Gao, Zhuowei*; Gao, Lei*Frontiers in Pharmacology, 2022, 12: 801730.被引 11
  • Corilagin alleviates liver fibrosis in zebrafish and mice by repressing IDO1-mediated M2 macrophage repolarization
    Wang, Yuhua; Huang, Sha; Kong, Wen; Wu, Chaofeng; Zeng, Ting; Xie, Shuwen; Chen, Qing; Kuang, Shanshan; Zheng, Ruise; Wang, Fengsui; Zhou, Chuying; Chen, Yuyao; Huang, Shaohui; Lv, Zhiping*PHYTOMEDICINE, 2023, 119: 155016.被引 1
  • Ginsenoside-Rg1 acts as an IDO1 inhibitor, protects against liver fibrosis via alleviating IDO1-mediated the inhibition of DCs maturation
    Mo, Chan; Xie, Shuwen; Zeng, Ting; Lai, Yuqi; Huang, Sha; Zhou, Chuying; Yan, Weixin; Huang, Shaohui; Gao, Lei*; Lv, Zhiping*PHYTOMEDICINE, 2021, 84: 153524.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Food & Function
发表日期
2023-11-27
卷期
第 14 卷, 第 23 期
页码
10347-10361
DOI
10.1039/d3fo03858k
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82205086, 81904154]; Guangdong Basic and Applied Basic Research Foundation [81904154]; Outstanding Youth Development Scheme project of Southern Medical University [2018B030306012]; Young Elite Scientists Sponsorship Program by CACM [2018B030306012]; 2023 Henan Special Research Project of TCM on "Double First-Class" Construction [2022A1515220179]; Guangming District Economic Development Special Fund; National Natural Science Foundation of China; Guangdong Basic and Applied Basic Research Foundation; Outstanding Youth Development Scheme project of Southern Medical University; Young Elite Scientists Sponsorship Program by CACM; 2023 Henan Special Research Project of TCM on "Double First-Class" Construction

作者

  • Q

    Qin, Meng-chen (第一作者)

    southern med univ

  • L

    Li, Jun-jie

    southern med univ

查看全部 12 位作者收起作者
  • Z

    Zheng, Yan-tao

    southern med univ

  • L

    Li, Yun-jia

    southern med univ

  • Z

    Zhang, Yu-xue

    southern med univ

  • O

    Ou, Rou-xuan

    southern med univ

  • H

    He, Wei-yi

    southern med univ

  • Z

    Zhao, Jia-min

    southern med univ

  • L

    Liu, Su-tong

    1 · henan univ tradit chinese med

  • L

    Liu, Ming-hao (通讯)

    1 · henan univ tradit chinese med

  • L

    Lin, Hai-yan (通讯)

    univ chinese acad sci

  • G

    Gao, Lei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417